Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography

Matthew R. Sobansky, David S Hage

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

High-performance affinity chromatography (HPAC) was utilized to examine the binding of very low density lipoprotein (VLDL) with drugs, using R/S-propranolol as a model. These studies indicated that two mechanisms existed for the binding of R- and S-propranolol with VLDL. The first mechanism involved non-saturable partitioning of these drugs with VLDL, which probably occurred with the lipoprotein's non-polar core. This partitioning was described by overall affinity constants of 1.2 (±0.3)∈×∈106 M-1 for R-propranolol and 2.4 (±0.6)∈×∈106 M-1 for S-propranolol at pH 7.4 and 37 °C. The second mechanism occurred through saturable binding by these drugs at fixed sites on VLDL, such as represented by apolipoproteins on the surface of the lipoprotein. The association equilibrium constants for this saturable binding at 37°C were 7.0 (±2.3)∈×∈104 M-1 for R-propranolol and 9.6 (±2.2)∈×∈104 M-1 for S-propranolol. Comparable results were obtained at 20 and 27°C for the propranolol enantiomers. This work provided fundamental information on the processes involved in the binding of R- and S-propranolol to VLDL, while also illustrating how HPAC can be used to evaluate relatively complex interactions between agents such as VLDL and drugs or other solutes.

Original languageEnglish (US)
Pages (from-to)6203-6211
Number of pages9
JournalAnalytical and Bioanalytical Chemistry
Volume406
Issue number25
DOIs
StatePublished - Jan 1 2014

Fingerprint

Drug interactions
Affinity chromatography
VLDL Lipoproteins
Drug Interactions
Affinity Chromatography
Propranolol
Pharmaceutical Preparations
Lipoproteins
Enantiomers
Apolipoproteins
Equilibrium constants
Association reactions

Keywords

  • Drug-protein binding
  • Frontal analysis
  • High-performance affinity chromatography
  • Propranolol
  • Very low density lipoprotein

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry

Cite this

Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography. / Sobansky, Matthew R.; Hage, David S.

In: Analytical and Bioanalytical Chemistry, Vol. 406, No. 25, 01.01.2014, p. 6203-6211.

Research output: Contribution to journalArticle

@article{81bd3e5e1f1449b793199074ae485389,
title = "Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography",
abstract = "High-performance affinity chromatography (HPAC) was utilized to examine the binding of very low density lipoprotein (VLDL) with drugs, using R/S-propranolol as a model. These studies indicated that two mechanisms existed for the binding of R- and S-propranolol with VLDL. The first mechanism involved non-saturable partitioning of these drugs with VLDL, which probably occurred with the lipoprotein's non-polar core. This partitioning was described by overall affinity constants of 1.2 (±0.3)∈×∈106 M-1 for R-propranolol and 2.4 (±0.6)∈×∈106 M-1 for S-propranolol at pH 7.4 and 37 °C. The second mechanism occurred through saturable binding by these drugs at fixed sites on VLDL, such as represented by apolipoproteins on the surface of the lipoprotein. The association equilibrium constants for this saturable binding at 37°C were 7.0 (±2.3)∈×∈104 M-1 for R-propranolol and 9.6 (±2.2)∈×∈104 M-1 for S-propranolol. Comparable results were obtained at 20 and 27°C for the propranolol enantiomers. This work provided fundamental information on the processes involved in the binding of R- and S-propranolol to VLDL, while also illustrating how HPAC can be used to evaluate relatively complex interactions between agents such as VLDL and drugs or other solutes.",
keywords = "Drug-protein binding, Frontal analysis, High-performance affinity chromatography, Propranolol, Very low density lipoprotein",
author = "Sobansky, {Matthew R.} and Hage, {David S}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00216-014-8081-4",
language = "English (US)",
volume = "406",
pages = "6203--6211",
journal = "Fresenius Zeitschrift fur Analytische Chemie",
issn = "0016-1152",
publisher = "Springer Verlag",
number = "25",

}

TY - JOUR

T1 - Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography

AU - Sobansky, Matthew R.

AU - Hage, David S

PY - 2014/1/1

Y1 - 2014/1/1

N2 - High-performance affinity chromatography (HPAC) was utilized to examine the binding of very low density lipoprotein (VLDL) with drugs, using R/S-propranolol as a model. These studies indicated that two mechanisms existed for the binding of R- and S-propranolol with VLDL. The first mechanism involved non-saturable partitioning of these drugs with VLDL, which probably occurred with the lipoprotein's non-polar core. This partitioning was described by overall affinity constants of 1.2 (±0.3)∈×∈106 M-1 for R-propranolol and 2.4 (±0.6)∈×∈106 M-1 for S-propranolol at pH 7.4 and 37 °C. The second mechanism occurred through saturable binding by these drugs at fixed sites on VLDL, such as represented by apolipoproteins on the surface of the lipoprotein. The association equilibrium constants for this saturable binding at 37°C were 7.0 (±2.3)∈×∈104 M-1 for R-propranolol and 9.6 (±2.2)∈×∈104 M-1 for S-propranolol. Comparable results were obtained at 20 and 27°C for the propranolol enantiomers. This work provided fundamental information on the processes involved in the binding of R- and S-propranolol to VLDL, while also illustrating how HPAC can be used to evaluate relatively complex interactions between agents such as VLDL and drugs or other solutes.

AB - High-performance affinity chromatography (HPAC) was utilized to examine the binding of very low density lipoprotein (VLDL) with drugs, using R/S-propranolol as a model. These studies indicated that two mechanisms existed for the binding of R- and S-propranolol with VLDL. The first mechanism involved non-saturable partitioning of these drugs with VLDL, which probably occurred with the lipoprotein's non-polar core. This partitioning was described by overall affinity constants of 1.2 (±0.3)∈×∈106 M-1 for R-propranolol and 2.4 (±0.6)∈×∈106 M-1 for S-propranolol at pH 7.4 and 37 °C. The second mechanism occurred through saturable binding by these drugs at fixed sites on VLDL, such as represented by apolipoproteins on the surface of the lipoprotein. The association equilibrium constants for this saturable binding at 37°C were 7.0 (±2.3)∈×∈104 M-1 for R-propranolol and 9.6 (±2.2)∈×∈104 M-1 for S-propranolol. Comparable results were obtained at 20 and 27°C for the propranolol enantiomers. This work provided fundamental information on the processes involved in the binding of R- and S-propranolol to VLDL, while also illustrating how HPAC can be used to evaluate relatively complex interactions between agents such as VLDL and drugs or other solutes.

KW - Drug-protein binding

KW - Frontal analysis

KW - High-performance affinity chromatography

KW - Propranolol

KW - Very low density lipoprotein

UR - http://www.scopus.com/inward/record.url?scp=84920707348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920707348&partnerID=8YFLogxK

U2 - 10.1007/s00216-014-8081-4

DO - 10.1007/s00216-014-8081-4

M3 - Article

VL - 406

SP - 6203

EP - 6211

JO - Fresenius Zeitschrift fur Analytische Chemie

JF - Fresenius Zeitschrift fur Analytische Chemie

SN - 0016-1152

IS - 25

ER -